scholarly journals Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals

Liver Cancer ◽  
2018 ◽  
Vol 7 (2) ◽  
pp. 190-204 ◽  
Author(s):  
Fabian Finkelmeier ◽  
Georg Dultz ◽  
Kai-Henrik Peiffer ◽  
Bernd Kronenberger ◽  
Franziska Krauss ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
De Novo ◽  
Direct Acting Antivirals ◽  
Hcv Treatment ◽  
Direct Acting ◽  
De Novo Hepatocellular Carcinoma

A genetic risk score predicts de novo hepatocellular carcinoma in hepatitis C cirrotic patients treated with direct-acting antivirals

2020 ◽  
Vol 73 ◽  
pp. S208-S209
Author(s):  
Elisabetta Degasperi ◽  
Enrico Galmozzi ◽  
Serena Pelusi ◽  
Roberta D’ambrosio ◽  
Roberta Soffredini ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis C ◽  
Risk Score ◽  
Genetic Risk ◽  
De Novo ◽  
Genetic Risk Score ◽  
Direct Acting Antivirals ◽  
Direct Acting ◽  
De Novo Hepatocellular Carcinoma

scholarly journals Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence

Medicine ◽  
2020 ◽  
Vol 99 (6) ◽  
pp. e18948 ◽  
Author(s):  
Antonio Riccardo Buonomo ◽  
Riccardo Scotto ◽  
Carmine Coppola ◽  
Biagio Pinchera ◽  
Giulio Viceconte ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
De Novo ◽  
Hepatitis C Virus Infection ◽  
Direct Acting Antivirals ◽  
Direct Acting ◽  
De Novo Hepatocellular Carcinoma
Sign in / Sign up

Export Citation Format

Share Document